GB
Gail Boudreaux
President and CEODirector

Gail Boudreaux insider trades: Elevance Health (ELV) stock buys and sales

President and CEO, Elevance Health Last trade Jul 17, 2026 147 Form 4 filings
$0
Sold, last 12 months
0 sales
$1.0M
Bought, last 12 months
1 buy
14
Open-market trades
since 2008
9
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Gail reports to the SEC

and 3 more companies

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 17, 2026ELV↑ Buy$1.0M
Jul 18, 2025ELV↑ Buy$2.4M
Jul 22, 2024ELV↓ Sell$17.0M
Jan 30, 2020ANTM↑ Buy$2.0M
Feb 5, 2019ZBH↑ Buy$250K
Sep 20, 2016NVAX↑ Buy$145K
Feb 28, 2014UNH↓ Sell$6.9M
Feb 26, 2013UNH↓ Sell$4.7M
Feb 15, 2013XEL↑ Buy$50K
Sep 7, 2012UNH↓ Sell$2.9M
Sep 7, 2012UNH↓ Sell$672K
Feb 23, 2012UNH↓ Sell$4.8M
Jan 12, 2012UNH↓ Sell$5.6M
Jul 28, 2008UNH↑ Buy$335K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ELV insiders

Open-market trades in the last 12 months

About Gail Boudreaux's insider trades

Gail Boudreaux is President and CEO at Elevance Health (ELV). Since Jul 28, 2008, Gail has reported 7 open-market purchases worth $6.2M and 7 sales worth $42.6M on SEC Form 4. In the last 12 months: 1 buy ($1.0M).

Their filings also include grants and awards (119 filings), shares withheld for taxes (28 filings), option exercises (7 filings), gifts (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.